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Abstract
Background: The human placenta facilitates the exchange of nutrients, gas and waste between the fetal and
maternal circulations. It also protects the fetus from the maternal immune response. Due to its role at the feto-
maternal interface, the placenta is subject to many environmental exposures that can potentially alter its epigenetic
profile. Previous studies have reported gene expression differences in placenta over gestation, as well as inter-
individual variation in expression of some genes. However, the factors contributing to this variation in gene
expression remain poorly understood.
Results: In this study, we performed a genome-wide DNA methylation analysis of gene promoters in placenta
tissue from three pregnancy trimesters. We identified large-scale differences in DNA methylation levels between
first, second and third trimesters, with an overall progressive increase in average methylation from first to third
trimester. The most differentially methylated genes included many immune regulators, reflecting the change in
placental immuno-modulation as pregnancy progresses. We also detected increased inter-individual variation in the
third trimester relative to first and second, supporting an accumulation of environmentally induced (or stochastic)
changes in DNA methylation pattern. These highly variable genes were enriched for those involved in amino acid
and other metabolic pathways, potentially reflecting the adaptation of the human placenta to different
environments.
Conclusions: The identification of cellular pathways subject to drift in response to environmental influences
provide a basis for future studies examining the role of specific environmental factors on DNA methylation pattern
and placenta-associated adverse pregnancy outcomes.
Background
The human placenta is a temporary organ that facilitates
the exchange of nutrients, gas and waste between mater-
nal and fetal circulations. In order to carry out these
functions, it is comprised of heterogeneous cell types
including several trophoblast cell populations (cytotro-
phoblasts, extra-villous trophoblasts and
syncytiotrophoblast), fibroblasts, mesenchymal cells, as
well as fetal and maternal vascular tissue and blood
cells. The extra-villous trophoblast cells must first
invade the maternal decidua and remodel maternal
arteries, to allow direct contact between maternal blood
and the placental syncytiotrophoblast cell layer [1]. In
addition to these traditional roles, the placenta is also
important in shielding the developing fetus from the
maternal immune system [2].
The placenta also undergoes several physiological
changes throughout gestation, with one of the most sig-
nificant being the flooding of placenta villi by maternal
blood at the end of the first trimester (~12 weeks
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gestation), resulting in a rise in oxygen concentration as
well as a decrease in trophoblast invasion. It is believed
that the inability of the placenta to respond to this
change in oxygen concentration can lead to placental
disease, such as preeclampsia [3,4].
The molecular mechanisms behind these morphologi-
cal and functional changes are now beginning to be
understood at both the gene-specific and genome-wide
level. Wide-ranging genome-wide gene expression differ-
ences between placentas at different gestational ages
were reported in two recent studies [5,6]. Despite sam-
pling from different locations within the placenta, many
changes were found in common between the two stu-
dies, each of which reported changes in expression with
increasing gestational age in genes involved in cell cycle
and immune response. This suggests that gene expres-
sion changes are needed for physiological needs of the
developing placenta, such as shielding the fetus from the
maternal immune system [2]. Genes involved in Wnt
signalling also showed expression changes over time
[5,6] that resulted in decreasing levels of b-catenin later
in gestation, possibly linked to decreasing placental inva-
siveness [6].
The importance of epigenetic factors in placental
development and function has long been known through
the study of imprinted genes [7,8] and it is increasingly
clear that the placenta displays a unique epigenetic pro-
file. However, the extent to which epigenetic modifica-
tions, specifically DNA methylation, contribute to
placental function have only recently been widely exam-
ined (reviewed in [9].
Due to its role as the interface between the mother
and fetus, the placenta is exposed to a myriad of envir-
onmental factors, some of which have been shown to
alter placental gene expression, as well as epigenetic
marks [10]. These include diet [11,12], smoking [13],
and assisted reproductive techniques [14,15]. Mounting
evidence implicates epigenetic marks, such as DNA
methylation, in mediating environmentally-induced reg-
ulation of genome function. More studies into the
effects of the environment on the placental epigenome
are warranted due the importance of this organ in regu-
lating pregnancy development.
Several genome-scale DNA methylation studies have
focused on finding tissue-specific differentially methy-
lated regions (tDMRs) between placenta and maternal
blood, as a means of detecting placental pathologies and
fetal chromosomal trisomies using non-invasive methods
(reviewed in [16-19]. This strategy has recently resulted
in the development of the first non-invasive blood test
for Down syndrome [20]. However, we, and others have
revealed substantial inter-individual DNA variation in
placental methylation profile [21,22], with a subset of
CpG sites more likely to be differentially methylated
between unrelated individuals. We proposed that these
CpG sites may be especially susceptible to environmen-
tally-induced changes associated with placental disease
[21]. In a follow-up investigation, we also observed a
gestational age difference in DNA methylation profile in
the placenta across the third trimester [23], while others
have recently reported an increase in global DNA
methylation levels between pre-term (28 weeks) and full
term placenta (40 weeks) [24].
The aim of the current study was to build on recent
knowledge obtained through genome-scale gene expres-
sion [5,6,25] and DNA methylation analysis [24,26] of
the human placenta. In the current study, we used the
Illumina Infinium HumanMethylation27 BeadChip plat-
form to identify promoter regions subject to change
throughout gestation. In addition we wanted to identify
those that become increasingly variable between indivi-
dual placentas over time, possibly in response to accu-
mulated environmental exposures.
Results
Genome-scale DNA methylation analysis of first, second,
and third trimester placenta
Genome-scale DNA methylation analysis of 18 first tri-
mester (8-12 weeks), 10 second trimester (17-24 weeks)
and 14 third trimester placenta (34-41 weeks) samples
was performed using the Illumina Infinium Human-
Methylation27 BeadChip (see Additional file 1; Data was
deposited into the NCBI Gene Expression Omnibus,
accession number: GSE31781). Following normalisation
and data cleaning (see Methods), a total 26, 162 probes
were available for subsequent analysis. Correlations (r2)
of average methylation of probes between gestational
ages ranged from 0.935 (first v third trimester) to 0.97
(second v third trimester; see Additional file 2). Unsu-
pervised hierarchical clustering of all probes clearly
delineates samples according to gestational age (Figure
1) with further evidence for a closer relationship
between second and third trimester profile than with
first trimester. Validation of methylation levels at 12
Infinium probes (representing 12 genes) in 9 placental
samples (total data points: 49) using the Sequenom Epi-
TYPER platform confirmed the robust nature of the
Infinium data (r2 = 0.76) (see Additional file 3). The
probes used for validation were chosen due to their
association with genes with known or predicted impor-
tant roles in regulating placental function (Additional
file 4).
Transition to normoxia is not associated with major
changes in placental DNA methylation profile
Despite the overall interspersed pattern of clustering of
first trimester samples of various gestations (8 - 12
weeks) (Figure 1), we tested to see whether any genomic
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regions undergo selective changes in methylation during
the transition from early first trimester to late first/early
second trimester. This is the period widely regarded as
the time when placental intervillous space is flooded
with oxygenated maternal blood. Only limited DNA
methylation differences were observed between 8 and 12
week placentas (Additional file 5). A total of only 12
probes (3 hypomethylated and 9 hypermethylated at 12
weeks relative to 8 weeks) showed consistent methyla-
tion differences (Δb) of 0.2 between the two gestational
ages. This suggests that promoter DNA methylation
plays a limited role in any physiological changes in the
placenta that occur in response to altered oxygen status.
Gestational age is associated with promoter methylation
levels
In order to gauge the effects of gestational age on the
overall methylation level at gene promoter regions
enriched on the Infinium HumanMethylation27 Bead-
Chip, the mean methylation across all probes (Methyla-
tion Index - MI) was calculated for each sample (Figure
2). The mean MI for first, second and third trimester
placenta was 0.240, 0.242 and 0.256, respectively. Thus,
there is an overall increase in methylation between sec-
ond and third trimesters (p = 5 × 10-5, student’s t-test).
No significant differences were detected between first
and second trimesters (p = 0.46) (Figure 2). This is
clearly apparent when the relative methylation levels for
all probes are displayed in a scatterplot (Additional file
2). All 3 trimesters have the same proportion of probes
with b-values between 0 and 0.2 (~63% of total probe
number). However, as gestation progresses, there is an
increase (from 13% to 17%) of highly methylated probes
(b > 0.6) (Additional file 6).
Absolute differences in mean methylation between
first and second, first and third, and second and third
trimesters were generally small, with only 149, 954 and
157 probes respectively, showing Δb > 0.2 (Table 1).
Further analysis showed that the 883 probes that
increased in methylation from first to third trimester
were predominantly those with intermediate methylation
levels (average b range 0.3 - 0.5) in the first trimester
(Additional file 7). Figure 3 shows a heat map with
unsupervised clustering of samples based on the 954
probes showing a Δb > 0.2 between 1st trimester and
term. Importantly, samples from all three trimesters
showed distinct methylation patterns. More specifically,
second trimester samples did not cluster with either the
first trimester or term samples, suggesting a progressive
Figure 1 Cluster dendrogram based on all autosomal Infinium
probes distinguishes placentas of different gestational age.
Dendrogram showing the relationship between placental samples
from three gestational ages based on DNA methylation levels (b-
values) of all analysable Infinium probes. All samples clustered
within their gestational age group, with no overlap between
gestations, suggesting there are consistent genome-scale DNA
methylation patterns associated with each gestational age. First
trimester samples clustered away from second and third trimester
samples, indicating that overall Infinium methylation patterns are
more similar in second and third trimester compared to first
trimester.
Figure 2 Average methylation of all samples for first, second
and third trimester. Methylation Index (MI) was calculated for each
sample by calculating the mean of all analysable Infinium b-values
(26, 162 probes) for that sample. The MIs were then grouped by
gestation and shown as box and whisker plots. First and second
trimester placentas show a similar overall level of methylation (p =
0.46) with median MIs of 0.238 and 0.241, respectively. Third
trimester samples show significantly elevated average MI values
(median = 0.256) relative to both first and second trimester,
indicating that there is a significant increase in methylation level
from second to third trimester.
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change in methylation across gestation. Interestingly,
none of the probes showed a ‘fluctuating’ pattern of
methylation across gestation (i.e. showed a similar level
of methylation in first and third trimesters, but hypo/
hypermethylation in second trimester) based on our cri-
teria of Δb > 0.2, and only 103 probes showed this pat-
tern with a Δb > 0.1. This further suggests that most
methylation changes occur in a progressive manner.
Changes in cell composition, primarily a decrease in
cytotrophoblasts, from first to third trimester could be one
the major factors contributing to methylation differences
between the two gestational time points. In order to test
this, methylation levels between purified first trimester
cytotrophoblasts and first and third trimester placenta,
were examined using both Infinium and Sequenom Epi-
TYPER analyses (22 data points) (Additional file 8).
Methylation levels in purified cytotrophoblasts were more
similar to first trimester placental tissue (r2 = 0.96 and
0.93) than third trimester (r2 = 0.88 and 0.88) as calculated
by Infinium and Sequenom EpiTYPER, respectively.
Table 1 Number of probes showing differential methylation between first, second and third trimester placental tissue.
Comparison Differentially methylated probes
(adj. p < 0.05)
Difference b ≥ 0.1 and adj. p < 0.05 Difference b ≥ 0.2 and adj. p < 0.05
First v Second 8, 240 411 ↓
1, 077 ↑
12 ↓
137 ↑
First v Third 8, 298 755 ↓
2, 581 ↑
71 ↓
883 ↑
Second v Third 7, 669 288 ↓
1, 515 ↑
6 ↓
151 ↑
↑: Increase in methylation; ↓: Decrease in methylation
Figure 3 Unsupervised clustering based on probes with Δb > 0.2 between First and Third trimester. HeatMap showing unsupervised
clustering of all placenta samples (x-axis) based on 954 probes with a Δb > 0.2 between First and Third trimester (y-axis). The majority of
differentially methylated probes show higher methylation in third trimester (883 probes) compared to only 71 probes with lower methylation in
third trimester. Second trimester placentas cluster as a separate group, and show a methylation profile that is an intermediate of first and third
trimesters. Green corresponds to low methylation and Red to high methylation.
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Differentially methylated genes between first trimester,
second trimester and term
Probes that showed differences of Δb > 0.2 (approximat-
ing 20% differential methylation) between each of the
three gestational ages, (Table 1), were analysed using
Ingenuity Pathways Analysis (IPA). Enrichment of net-
works, pathways and gene functions was calculated
using the Ingenuity Pathways software. Top enriched
canonical pathways for genes differentially methylated
between first and second trimesters (110 genes), first
and third trimesters (654 genes) and between second
and third trimesters (106 genes) are listed in Table 2.
‘Communication between innate and adaptive immune
cells’ was the most significantly enriched pathway, with
at least 4 of the top 5 pathways in each comparison
being immune-related.
Inter-placental methylation variation increases with
gestational age
DNA methylation may be modulated in part by environ-
mental influences and may serve as a mediator between
the environment and genome function (reviewed in
[27]). We previously investigated the inter-individual
variability of DNA methylation in the human placenta
[21] and proposed that the highly variable methylation
found in the placenta may be a consequence of cumula-
tive response to the intrauterine environmental expo-
sures [28]. To test this further, we calculated the inter-
placental variance of all probes within each of the first,
second and third trimester time points. While the vast
majority of probes (95-98%) showed very little variation
(s2 < 0.009) at all time points, the number with an
inter-placental variance of > 0.01 was increased in the
third trimester relative to the earlier time points (Figure
4). More specifically, the third trimester group was
enriched for probes with the highest variance (s2 >
0.02), with 352 such probes compared to 106 (c2 =
133.3, p < 0.001) and 166 (c2 = 66.7, p < 0.001) in first
and second trimester placentas respectively (Additional
file 9). To facilitate the comparison of variation level
between trimester groups, we defined sites with variance
> 0.02 as highly variable in methylation.
Further analysis revealed that most of the gestational
age associated variation was found in probes with
intermediate methylation (0.2 < b < 0.6) rather than
low (b < 0.2) or high (b > 0.6) methylation (Additional
file 10; Additional file 9). This suggests that the
increased variation observed between different full-
term placentas is not necessarily a by-product of
increasing methylation across gestation. In addition,
the increasing methylation across gestation also sug-
gests that the increasing variability was unlikely caused
by a lack of maintenance of DNA methylation by
DNMTs in the human placenta.
While inter-individual variation of DNA methylation
may in part reflect genetic polymorphisms [29], this
source of variation would be anticipated to be repre-
sented equally across all 3 gestational ages. To investi-
gate the inter-placental variation of methylation in
more detail, variance level of probes for the third tri-
mester was plotted against the first trimester (Figure
5). This revealed that the majority of the highly
Table 2 Top Canonical Pathways from IPA for probes showing differential methylation across gestation
First v Second trimester p-value # differentially methylated genes/# genes in the pathway
Communication between Innate and Adaptive Immune Cells 6.39E-05 6/109
Role of Cytokines in Mediating Communication between Immune Cells 1.53E-03 4/56
Altered T Cell and B Cell Signaling in Rheumatoid Arthritis 6E-03 4/92
Calcium Signaling 6.81E-03 6/204
Crosstalk between Dendritic Cells and Natural Killer Cells 1.04E-02 4/97
Second v Third trimester p-value # differentially methylated genes/# genes in the pathway
Systemic Lupus Erythematosus Signaling 4.72E-03 5/166
Crosstalk between Dendritic Cells and Natural Killer Cells 8.2E-03 4/97
Role of NFAT in Regulation of the Immune Response 2.05E-02 5/199
Agrin Interactions at Neuromuscular Junction 2.35E-02 3/69
Wnt/b-catenin Signaling 2.51E-02 5/172
First v Third trimester p-value # differentially methylated genes/# genes in the pathway
Communication between Innate and Adaptive Immune Cells 1.69E-07 17/109
Systemic Lupus Erythematosus Signaling 1.9E-06 21/166
Role of Cytokines in Mediating Communication between Immune Cells 1.43E-05 12/56
Altered T Cell and B Cell Signaling in Rheumatoid Arthritis 1.79E-04 13/92
Crosstalk between Dendritic Cells and Natural Killer Cells 2.61E-04 14/97
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variable sites “gain” variability in the later gestations
(area (c) in Figure 5). Numerically, the probes with
the highest variance are found exclusively in the third
trimester (223), while far fewer probes show high var-
iation across all three gestations (47) (Additional file
11).
The top pathways for genes that show variable methy-
lation at each gestastional age are listed in Table 3. The
top 5 pathways in the third trimester include ‘amino
acid metabolism’, while first and second trimester lists
both include ‘circadian rhythm signalling’. This supports
our hypothesis of an increasing accumulation of epige-
netic variation in response to cumulative environmental
exposures.
CpG density and genomic context influence variability in
placental methylation
In order to examine the relationship between CpG den-
sity and methylation status, probe locations were
assigned to either CpG Island (CGI) or non-CpG Island
(non-CGI) genomic regions, as annotated by Illumina.
Using a chi square test, we found that probes showing
increased methylation across gestation were enriched for
non-CGI regions (c2 = 480.2, p < 0.001), while probes
showing lower methylation in third compared to first
trimester were not context dependent (c2 = 2.68, p =
0.14 (Additional file 12). We also examined the genomic
context of the variable probes falling within the three
categories shown in Figure 5(A-C). Probes with high
variation in both first and third trimester (Additional
file 12-D) are associated with CGIs (p < 0.05). Variable
probes in the first, but not the third trimester are
slightly enrichmed for CGI regions (p = 0.05), and those
that were variable in third, but not first trimester show
a strong association with CGIs (p < 0.001) (Additional
file 12). We also looked at the relationship between the
distance from transcription start site and DNA methyla-
tion. There was no association with distance from TSS
and differential or variable methylation (data not
shown).
DNA methylation profile influences global gene
expression in the placenta
In order to assess the overall effect of DNA methylation
on gene expression profile, methylation b-values levels
for first, second and third trimester placental tissue
were correlated with publicly available expression data
for matched gestational age placenta [5,6]. Infinium
probes were quartiled according to methylation level,
with b value ranges of 0.01-0.06 (bottom 25% of probes),
Figure 4 Number of variable probes increases with gestation. The number of probes with high inter-individual variation increases over
gestation. Variance (s2) of each probe was calculated for each gestational age. The number of probes (y-axis; log10 scale) showing a particular
level of variance (x-axis) is shown. Most probes (95% in third trimester to 98% in first trimester) show low variation (s2 < 0.009). However, there is
an increase in the number of variable probes (s2 > 0.02) in third trimester placentas, and to a lesser extent second trimester placentas, compared
to first trimester.
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Table 3 Top Canonical Pathways for gene-associated probes that show variable methylation within each gestational
age
Variable in First trimester p-value genes
Arachidonic Acid Metabolism 6.97E-04 CBR1, CYP2E1, GPX7, PNPLA3, PTGS1
Hepatic Fibrosis/Hepatic Stellate Cell Activation 1.36E-02 CYP2E1, ECE1, FGFR1, MYL5
Circadian Rhythm Signaling 1.91E-02 GRIN3A, VIPR2
Calcium Signaling 2.69E-02 CHRNB4, GRIA4, GRIN3A, MYL5
Nitrogen Metabolism 3.54E-02 PTPRG, VNN3
Variable in Second trimester p-value genes
Circadian Rhythm Signaling 3.39E-03 GRIN3A, VIPR2, PER1
Glutathione Metabolism 1.62E-02 GPX3, GPX7, GSTO1
Arachidonic Acid Metabolism 1.86E-02 CBR1, CYP2E1, GPX3, GPX7
Sonic Hedgehog Signaling 3.7E-02 DYRK1B, HKR1
Metabolism of Xenobiotics by Cytochrome P450 4.68E-02 ADHFE1, CYP2E1, GSTO1
Variable in Third trimester p-value genes
Glutamate Receptor Signaling 6.1E-03 GRID2, GRIK2, GRIN3A, GRM6, SLC1A6
Valine, Leucine and Isoleucine Degradation 1.13E-02 ACADL, ALDH1A3, ELOVL2, IVD, OXCT1
b-alanine Metabolism 2.07E-02 ACADL, ALDH1A3, DPYS, IVD
Butanoate Metabolism 3.74E-02 ALDH1A3, ELOVL2, OXCT1, PDHA2
Tyrosine Metabolism 4.19E-02 ADHFE1, ADLH1A3, ELOVL2, MGMT
Figure 5 Variance levels of probes in the third compared to the first trimester. Scatter plot of probe variance (s2) at first trimester (x-axis)
and third trimester (y-axis). Dots represent individual probes and the vertical red dotted line marks s2 = 0.02 for first trimester, while the
horizontal red dotted line marks s2 = 0.02 for third trimester. Probes on the outside of the red line are deemed ‘variable’. This analysis revealed
that there are 73 probes (A) which are highly variable in both first and third trimester. Only 33 probes (B) were variable in first, but not third
trimester, while 279 probes (C) were variable in third, but not first trimester. This analysis suggests that most of the variable probes become so
throughout pregnancy, supporting the hypothesis that accumulating environmental factors contribute to inter-individual variation in DNA
methylation, in term placenta.
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0.06-0.15 (25-50%), 0.15-0.47 (50-75%) and 0.47-0.98
(top 25% of probes), and plotted against gene expression
levels for linked genes data (Additional file 13). A gen-
eral decrease in median expression level with increasing
methylation level was observed for all three gestational
ages. In particular, there was a distinct down regulation
in median gene expression between the second (50%) to
third quartiles (75%) associated with a change in methy-
lation range from b < 0.15 to b > 0.15. In addition the
range of expression was reduced in the higher methyla-
tion quartiles (Additional file 13). Using the same
expression data sets, we plotted methylation change
from first to third trimester against changes in gene
expression across the same time points (Figure 6).
While methylation change of less than 0.2 were gener-
ally not associated with changes in gene expression, sev-
eral genes showed both higher methylation and lower
expression in third trimester compared to first trimester.
These included several immune-regulators ranked highly
by IPA (CCR7 and CCL21) and one with known func-
tion in placental development (GNLY; Granulysin) (Fig-
ure 6). Additional file 14 lists additional genes that
showed concordant differences in methylation and
expression between first and third trimesters.
Discussion
In this study we performed genome-wide DNA methyla-
tion analysis of gene promoter regions, using the
Illumina Infinium HumanMethylation27 BeadChip, in
placentas of different gestational ages (18 first trimester
(8-12 weeks), 10 second trimester (17-23 weeks), and 14
third trimester samples (34-41 weeks)). We further vali-
dated the array data by targeting 12 CpG sites (covering
12 gene promoters) using the Sequenom EpiTYPER
platform. The correlation of r2 = 0.76 between the two
platforms is comparable to that published for similar
comparisons [30]. We found evidence for both a pro-
grammed change of methylation in gene promoters
across gestation and an increase in variability of methy-
lation as gestation progresses. We predict that this is
directly related to the cumulative effect of intrauterine
environmental exposure, however, the contribution of
stochastic events to the observed variation cannot be
discounted at this time. Further investigation is war-
ranted to determine the effects of specific environmental
exposures on DNA methylation patterns of the genes
identified as variable in the present study.
Unsupervised clustering based on all Infinium probes
(excluding those on the sex chromosomes) clearly sepa-
rated all samples by gestational age, with first trimester
samples clustering away from second and third trimester
samples (Figure 1). This indicates that there are consis-
tent, large scale changes in DNA methylation across
gestation. There are several possible explanations for
these temporal differences, one of which is the change
in cell composition and differentiation from first to
Figure 6 Correlation between methylation and gene expression change between first and third trimester. Methylation difference (Δb)
between first and third trimester (x-axis) was plotted against gene expression log fold change (y-axis) between first and third trimester. A
positive change in log fold expression indicates higher expression in first trimester, while a positive change in methylation indicates higher
methylation in the third trimester. Therefore, the top left panel includes genes which showed lower methylation and higher expression in first
compared to third trimester. The three highlighted genes (CCR7, GNLY and CCL21) ranked highly in IPA analysis. Grey dots represent Infinium
probes. Black dots represent specific genes of interest.
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third trimester, especially the relative loss of cytotropho-
blasts throughout gestatation, (85% of the total tropho-
blast population in first trimester but only 15% of the
trophoblast volume at full term) [31]. In support of this
playing at least a partial role in the observed change in
methylation over time, we found a slightly higher corre-
lation between the methylation profile of purified pri-
mary cytotrophoblasts with first trimester placental
tissue (R2 = 0.96) than with third trimester tissue (R2 =
0.88; see Additional file 8). Similar data have recently
been reported for second trimester placenta tissue
which has been shown to be more similar to cytotro-
phoblasts than mesenchyme in terms of methylation
profile [32]. However, the greater part of trophoblast
volume at full term is syncytiotrophoblast, arising from
the fusion of cytotrophoblast cells into a multinucleated
layer. Thus, the observed trend of increasing methyla-
tion may equally be due to differentiation of the cytotro-
phoblast component, or alternatively, may even be due
to other aspects of altered placental function known to
occur as gestation progresses.
Despite the interspersed clustering of first trimester
samples based on the overall Infinium methylation pat-
terns, we were interested in assessing DNA methylation
changes occurring at the transition from the first to the
second trimester. This period of placental development
is characterised by the loosening of trophoblast plugs
and the associated rise in oxygen concentration from 2-
3%, to 7-8% [33]. The rapid increase in oxygen levels
can lead to the accumulation of reactive oxygen species
(ROS), which might be linked to the reduction in tro-
phoblast invasion and migration observed at about this
time. Furthermore, it has been suggested that the inabil-
ity of the placenta to adapt to this increase in oxygen
concentration may lead to the development of pree-
clampsia [3]. In this study, we found only 12 CpG sites
with Δb > 0.2 between these time points, suggesting
that DNA methylation changes are unlikely to play a
major role in the physiological changes in placentation
associated with transition from low oxygen to a normal
oxygen environment. It must be noted however, that we
do not have data on the level of vascularisation for our
placental samples, so it is possible that flooding of the
maternal blood may not have occurred at the time the
12 week tissue was collected.
The separation of the trophectoderm from the inner
cell mass at the blastocyst stage occurs at a time when
genome-wide DNA methylation levels are at their lowest
[34]. The subsequent re-establishment of methylation
marks occurs at a slower rate, and to a lesser extent, in
the extra-embryonic lineage compared to somatic tissues
[34]. This accounts for the low global DNA methylation
in human placenta, which is more similar to human
tumours, and is mostly due to hypomethylation of
repetitive elements [35,36]. A recent study has reported
a positive correlation between global DNA methylation
levels (as measured by an ELISA-like assay with 5-
methylcytosine antibody) and gestational age in the pla-
centa [24], supporting our data for an increasing level of
promoter-associated DNA methylation during gestation,
particularly from second to third trimester (Figure 2).
This accumulation of methylation was most apparent in
genomic regions that showed an intermediate level of
methylation in first trimester, suggesting that these
genes are the most likely to be epigenetically regulated
by DNA methylation. Furthermore, these CpG sites
were more likely to be in lower CpG density regions
(non-CGI) (see Additional file 12) suggesting that
methylation levels of CpG sites within CpG Islands are
more stable across gestation in this tissue. The higher
promoter methylation at term could also reflect the end
point of a continual process of re-methylation in the
extra embryonic lineage from the blastocyst stage, at
which point the genome is almost completely hypo-
methylated [34].
IPA analysis of genes showing differential methylation
between first and third trimesters indicated that the
most affected pathways were ‘communication between
innate and adaptive immune cells’ and other ‘immune-
related’ pathways (Table 2). Genes in common between
two or more of the top 5 immune-related pathways
included immune regulators CCR7, CD28, CSF2,
IFNA17, IFNA2, IFNA21, IFNB1, IL1F7, IL2, IL3, IL5,
LTA, TLR6, TLR9, TNF, TNFRSF13B and TNFSF13B.
This is in accordance with previous gene expression stu-
dies, which also showed substantial enrichment of
immune regulators amongst the most differentially
expressed genes in placenta at different gestational ages
[5,6]. Several immune-regulators showed a strong corre-
lation between methylation and expression change from
first to third trimester, including Granulysin (GNLY),
which has previously been implicated in spontaneous
abortions [37] (Figure 6). Given the critical role of the
placenta in modulating the maternal immune response
to the developing pregnancy, and mounting evidence for
a role of environmental exposures in controlling both
immune-system development and epigenetic profile, it is
not surprising that immune regulators are amongst the
most variably methylated gene groups.
In addition to identifying CpG sites that consistently
change over gestation, we were also interested in CpG
sites that show inter-individual variability within each
gestational age. Genes that show inter-individual differ-
ences in expression in placenta have previously been
described by Sood et al. [25]. We have previously
reported a subset of CpG sites showing variable methy-
lation in term placenta between unrelated individuals,
and suggested that these CpG sites may be more
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susceptible to change under adverse conditions [21]. We
have now extended these findings by demonstrating that
although ~95% of all probes showed very little variation
(s2 < 0.01) between individuals, the number of highly
variable probes (s2 > 0.02) increased with gestational
age. Our data support a model whereby increasing varia-
bility in methylation profile between placentas arises in
response to cumulative differences in environmental
exposure rather than sequence polymorphisms (Figure
5). The most variable probes in the first trimester were
associated with genes involved in, ‘calcium signaling’
and ‘nitrogen metabolism’, while ‘circadian rhythm sig-
nalling’ and ‘arachidonic acid metabolism’ were
enriched in both first and second trimester placenta
(Table 3). The most enriched variable pathways at term
included ‘glutamate receptor signaling’, ‘valine, leucine
and isoleucine degradation’, and ‘b-alanine’, ‘butanoate’,
and ‘tyrosine’ metabolism. The enrichment of pathways
involved in metabolism further supports our hypothesis
that the methylation variation is occurring in response
to environmental influences, potentially as part of an
‘adaptive’ response of the developing pregnancy, thereby
allowing changes in gene expression that may be more
beneficial under altered environmental conditions [38].
The placental epigenome regulates placental gene
expression and function, and any disruption in placental
epigenetics (via either stochastic or environmental per-
turbation) has the potential to affect the developing
fetus. Therefore it will be interesting in future to exam-
ine the potential for role of placental epigenome varia-
tion with the now widely accepted phenomenon of ‘fetal
programming’ first described in the context of long
term effects of intrauterine environment on offspring
[39] and subsequently developed by Barker and collea-
gues in the early 1990s [40-42].
Finally, contrary to CpG sites that increase in methyla-
tion across gestation, variable CpG sites are more likely
to be located within CpG islands (Additional file 12).
This coupled with the finding that hypermethylated
probes (b > 0.6) do not show higher variation compared
to probes with low methylation levels (b < 0.2) (see
Additional file 10) suggests that increased variation in
late gestation is not a by-product of increasing methyla-
tion across gestation.
The direct role of DNA methylation in controlling
placental global gene expression levels was examined by
comparing our DNA methylation data with published
gene expression data for placenta tissue of the same
gestational age (Figure 6 and Additional files 13 and 14).
A general trend of decreasing expression in response to
increasing DNA methylation was found as expected.
Further, the range of expression also decreased in the
highly methylated probe group. These findings confirm
that promoter DNA methylation influences global gene
expression levels at all three gestational time points.
However, the large range in gene expression in all four
methylation quartiles, and the lack of strong correlation
between methylation and expression change across
gestation (Figure 6), support previous data that promo-
ter DNA methylation is only one of the mechanisms
controlling gene expression, with many other factors
combining to regulate the expression of genes, including
histone modifications, non-coding RNAs, and transcrip-
tion factors.
Conclusions
In the present study, we performed genome-scale DNA
methylation analysis of human placenta at three distinct
gestational ages, using the Infinium HumanMethyla-
tion27 array. This platform targets over 14, 000 genes,
however, is limited to the 5’ promoter region. Our find-
ings support the hypothesis that DNA methylation levels
in the human placenta are dynamic and change over
gestation, possibly in response to changing cellular com-
position and/or cumulative environmental influences.
The identification of pathways that are likely to be
affected by the latter (i.e. those that show higher varia-
tion at full term) will provide valuable candidates for
testing in studies examining placenta-associated adverse
pregnancy outcomes.
Methods
Sample collection
Use of cells and DNA isolated from 8- and 12-week
gestational tissue of normal pregnancies was approved
by the Cambridgeshire Research Ethics committee
(CREC 04/Q0108/23). Additional 1st trimester (8-12
week gestation) and 2nd trimester (17-24 week gestation)
placental tissue was collected from elective abortions
with the approval from the ethics committees of the
University of British Columbia and the Children’s &
Women’s Health Centre of British Columbia. Term pla-
cental tissue was collected as previously described
[21,23,43]. Detailed information of the placental samples
can be found in Additional file 1.
DNA extraction
Tissue samples were incubated at 50°C overnight with
shaking in DNA extraction buffer (100 mM NaCl, 10
mM Tris.HCl pH8, 25 mM EDTA, 0.5% (w/v) SDS),
containing 200 μg/ml proteinase K. DNA was isolated
by two rounds of phenol:chloroform extraction, followed
by RNAse A treatment, precipitation in absolute ethanol
containing 10% (v/v) sodium acetate (3 M, pH 5.2), and
resuspended in 100 μl nuclease-free water (Ambion,
Austin, TX, USA) or using salting out method followed
by purification with Qiagen blood and tissue kit (Qia-
gen, Mississauga, ON, USA). DNA was stored at -20°C.
Novakovic et al. BMC Genomics 2011, 12:529
http://www.biomedcentral.com/1471-2164/12/529
Page 10 of 14
Infinium DNA methylation analysis
Infinium arrays were hybridized and scanned as per
manufacturer’s instructions (Illumina, San Diego, USA).
Individual probe b-values (range 0-1) were are approxi-
mate representations of the absolute methylation per-
centage of specific CpG sites within the sample
population. The values were derived by comparing the
ratio of intensities between the methylated and
unmethylated alleles using the following formula:
β value =
Max
(
Signal B, 0
)
[Max(Signal A, 0) +Max(Signal B, 0)]
Where Signal B is the array intensity value for the
methylated allele and Signal A is the non-methylated
allele. Samples were processed using the Bioconductor
package lumi, which is specifically designed for Illumina
data [44,45]. Samples were assessed for quality, color-
adjusted to take into account the difference between
batches, background-corrected and ssn normalized. Any
probe within a sample with a detection p value of 0.05
or greater was excluded from further analysis. Probes on
the × and Y chromosomes were removed from further
analysis to eliminate sex-specific differences in methyla-
tion, leaving 26, 162 analysable probes. A batch correc-
tion effect was applied to the data in order to remove
noise produced by processing samples at different times.
Differentially methylated probes were defined as having
a Δb > 0.2 between groups, with an adjusted (Benjamini)
p value < 0.1.
Gene Ontology and Pathway analysis
Data sets were interrogated using the Ingenuity Path-
ways Analysis (IPA) application (Ingenuity® Systems,
Redwood City, CA; http://www.ingenuity.com). IPA was
used to identify enriched canonical pathways, gene net-
works, functional classes, and toxicity lists (molecules
involved in known toxicity processes).
Locus-specific methylation analysis
Sequenom MassARRAY EpiTYPING was performed to
validate Infinium methylation, as previously described
[46]. Sequenom assays were designed to target specific
Infinium probes. Genomic sequences for assay design
were extracted from the UCSC genome browser http://
www.genome.ucsc.edu/. Primer pairs for amplification
were designed using EpiDesigner web tool http://www.
epidesigner.com/. The primers are listed in Additional
file 4. Amplification was performed after bisulfite con-
version of genomic DNA with the MethylEasy Xceed
bisulphite conversion kit (Human Genetic Signatures,
North Ryde, Australia). Amplification conditions were
40 cycles: 95°C for 5 min, 56°C for 1 min 30 sec and 72°
C for 1 min 30 sec, then 72°C for 7 min.
Raw data obtained from MassArray EpiTYPING was
cleaned systematically using an R-script with the follow-
ing three criteria (in order): (1) removal of samples that
failed across 100% of CpG sites, (2) removal of CpG
sites that failed (for example due to low or high mass,
silent peaks, or low intensity readings) across more than
40% of samples, and (3) removal of samples that failed
to generate data for more than 70% of CpG sites tested.
Publicly available gene expression microarray data
analysis
Gene expression data was downloaded from Gene
Expression Omnibus (Barrett and Edgar, 2006, Sayers et
al., 2009), (Database issue D885-D890). CEL files were
downloaded from series GSE9984 [6] and GSE5999 [5]
and processed with the Bio-conductor package ‘gcrma’
[47]. DNA methylation and gene expression data for the
corresponding gestational age was compared as pre-
viously described [48]. The two expression matrices
were merged based on probe ID as both were generated
using the same array platform, the Affymetrix Human
Genome U133A Array. Gene expression data was then
linked with the methylation data according to gene
name. Sample quartiles were produced from the methy-
lation data. The expression values of the genes in each
quartile were then plotted as box and whisker plots.
Additional material
Additional file 1: Summary of placental samples analysed in the
study.
Additional file 2: Correlations between average methylation in first,
second and third trimesters. Correlations between average methylation
in (A) first and second trimesters, (B) second and third trimesters, and (C)
first and third trimesters. This analysis revealed that first and third
trimester methylation was most discordant, as expected, while second
trimester placenta is more similar to third trimester placenta in terms of
overall promoter DNA methylation. Furthermore, this figure visually
shows the increase in methylation in third trimester compared to first
(C).
Additional file 3: Correlation between Infinium and Sequenom
methylation levels. Correlation between Infinium HumanMethylation27
BeadChip and Sequenom EpiTYPER locus-specific methylation analysis.
Methylation levels in 12 genes were measured using Sequenom
MassARRAY Epityping targeting the same CpG sites interrogated on the
Infinium BeadChip Arrays. Correlation between platforms was 0.76,
supporting the use of the Infinium HumanMethylation27 BeadChip for
profiling DNA methylation in this study. Genes interrogated are listed in
Additional file 4.
Additional file 4: Sequenom EpiTYPER primer sequences.
Additional file 5: Unsupervised clustering of first trimester placenta
based on differentially methylated probes between 8 and 12 weeks
gestation. HeatMap showing unsupervised clustering of 8 and 12 week
placenta samples based on 12 probes that showed a Δb > 0.2 between
8 week and 12 week placenta. The 12 probes were associated with 11
genes, with two probes associated with the BTG4 gene. White
corresponds to low methylation, and black to high methylation.
Additional file 6: Proportion of probes within a particular
methylation level. Pie Charts showing the proportion of probes within a
particular methylation level for first, second and third trimester. The
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percentage of probes with a ‘b < 0.02’ is the same in all three
gestational ages (63%), suggesting that probes with low methylation in
first trimester remain low over placental development. Furthemore our
data suggests that probes with an intermediate methylation in first
trimester are the ones that increase over gestation, with a lower
proportion of probes in the ‘b = 0.2 - 0.6 group’ in second (22%) and
third (20%) compared to 1st trimester (24%); and a higher proportion of
probes in the b > 0.6 group in 2nd (15%) and term (17%) placenta
compared to 1st trimester (13%).
Additional file 7: Average methylation level of probes that increase
in methylation over gestation. Box plot showing average methylation
of (A) all probes (n = 26, 162) in first, second and third trimester
placenta, and (B) probes that shown an increase in methylation from first
to third trimester of b > 0.2 (n = 883). This analysis shows that probes
with intermediate levels of methylation in first trimester are the ones
that increase over time. On the other hand, probes with low methylation
(b < 0.2) in the first trimester do not appear to increase in methylation in
the third trimester placenta.
Additional file 8: Correlation between methylation levels in purified
first trimester cytotrophoblasts and first and third trimester
placenta. Scatter plot showing correlation (r2) between first and third
trimester placenta and purified first trimester cytotrophoblasts
methylation, based on Infinium HumanMethylation27 BeadChip and
Sequenom EpiTYPER analysis. The correlations between first trimester
placenta and cytotrophoblasts were (A) 0.96 and (C) 0.93, and between
third trimester placenta and cytotrophoblasts were (B) 0.88 and (D) 0.88,
using Infinium and Sequenom platforms, respectively. This finding
suggests that both first and third trimester placenta methylation levels
are indicative of cytotrophoblast levels. The lower correlation in third
trimester is likely due to both lower numbers of villous cytotrophoblasts
and their differentiation into the syncytiotrophoblast layer.
Additional file 9: Number of probes showing variation at each
gestational age.
Additional file 10: Relationship between probe methylation level
and variation. Relationship between methylation level and inter-
individual variation at each gestational age (s2). Probes were separated
into three groups: (A) low methylation (b < 0.2), (B) intermediate
methylation (0.2 < b > 0.6) and (C) high methylation (b > 0.6). The
number of probes was plotted on the y-axis (in log10 scale) and the
variance (s2) on the x-axis. Probes with an intermediate methylation level
were most likely to show inter-individual variation (B), while probes with
a high methylation level were least likely to show inter-individual
variation. In fact, most of the probes with a variance of > 0.02 were from
the intermediate methylation level (88/106 first trimester, 119/166 second
trimester and 255/352 term), even though most of the Infinium probes
(63%) are actually in the low methylation group.
Additional file 11: Number of probes showing variation at each
gestational age. Venn diagram of variable probes (s2 > 0.02) in each
gestational age. This analysis revealed that the vast majority of variable
probes are only variable in third trimester, while 52 were only variable in
second, and 21 only in first trimester. A total of 47 probes were variable
across all gestational ages.
Additional file 12: Relationship between DNA methylation and
genomic context. Probes were separated into two groups based on
their genomic location - CpG Island (CGI) or non-CpG Island (non-CGI).
The expected frequency was based on the proportion of all analysable
Infinium probes (A) within a CGI or outside a CGI (0.76 and 0.24,
respectively). Probes that increased in methylation over gestation were
predominantly in non-CGI regions (B), while probes that decreased in
methylation over gestation showed the expected proportions.
Furthermore, probes that showed inter-individual variation in (D) both
first and third trimesters, (E) first trimester only, and (F) third trimester
only, were predominantly associated with CGIs. This finding further
suggests that probes that change over gestation are not the same as
those that show inter-individual variation within each gestation.
Additional file 13: Relationship between DNA methylation and gene
expression levels. Relationship between DNA methylation and gene
expression levels in first, second and third trimester placenta. Infinium
HumanMethylation BeadChip probes were quartiled into 4 groups (0-
25%, 25-50%, 50-75%, 75-100%) based on methylation level, with the
same number of probes in each quartile. The quartiles for each
gestational age were plotted on the x-axis with the corresponding gene
expression values obtained from publically available first, second and
third trimester data (y-axis). This analysis shows a decreasing median
gene expression level with increasing DNA methylation, highlighting the
functional relevance of DNA methylation in placenta at all three
gestational ages.
Additional file 14: Correlation between methylation and expression
change between first and third trimester with more genes
highlighted. Methylation difference (Δb) between first and third
trimester (x-axis) was plotted against gene expression log fold change (y-
axis) between first and third trimester. A positive change in log fold
expression indicates higher expression in first trimester, while a positive
change in methylation indicates higher expression in third trimester.
Highlighted genes are those that show a correlation between
methylation and expression level. Grey dots represent Infinium probes,
black dots represent most differentially methylated and expressed genes.
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